Osimertinib, Targeted therapy for EGFR mutated NSCLC, 3rd generation irreversible EGFR-TKI, CNS metastasis activity, Ex19Del or L858R mutations, EGFRm NSCLC,
Sale!
Lucius
Replica: EGFRm NSCLC Targeted Osimertinib 3rd Gen Therapy
Original price was: $668.00.$509.00Current price is: $509.00.
Osimertinib, Targeted therapy for EGFR mutated NSCLC, 3rd generation irreversible EGFR-TKI, CNS metastasis activity, Ex19Del or L858R mutations, EGFRm NSCLC,
Reviews
There are no reviews yet.